In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
In October 2019, a class-action lawsuit was filed against Sanofi-Aventis U.S., Sanofi US Services, Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals for allegedly failing to disclose that the over-the-counter heartburn medication…
Dig into these advertising claims.
Advisory opinion letter raises “serious concerns” with self-reg group’s guidance.
Emily Jankowski and Grace Tatter, WBUR | NPR
It may surprise you.
Verdict comes nine years after TINA.org alerted regulator to supplement’s unsubstantiated health claims.